Health News

Wednesday, April 16, 2014 - 08:43

A new blood test designed to detect hypermethylation of ten key breast cancer genes accurately detects advanced breast cancer. It has great potential as a method to detect recurrence in asymptomatic patients and monitor treatment response. These are the findings of a study led by researchers in Johns Hopkins Kimmel Cancer Center published on 15th April in the journal Cancer Research.


Tuesday, April 15, 2014 - 21:25

A new study demonstrates very high plasma levels of a protein called islet amyloid polypeptide (IAPP) in type 1 diabetes patients of recent onset. The study was conducted on serum or plasma samples obtained from a nationwide Swedish prospective cohort study that recruits new-onset Type 1 diabetes children.

Tuesday, April 15, 2014 - 16:00

A chimeric mouse model called TK-NOG which has a humanized liver would have predicted liver toxicity that developed in humans during the 1993 clinical trial of fialuridine. That is the major finding of a new study from researchers in Stanford University, the Center for the Advancement of Health and Biosciences and the Ely Lilly Department of Drug Disposition, all in California. The study is published on 15th April 2014 in the journal PLoS Medicine.


Tuesday, April 15, 2014 - 14:52

The study, published in today’s issue of the Proceedings of the National Academy of Sciences, suggests that mitochondrial operations could be a therapeutic target against hepatitis C, the leading cause of liver transplants and a major cause of liver cancer in the U.S.


Tuesday, April 15, 2014 - 14:43

It’s long been known that certain strains of human papillomavirus (HPV) cause cancer. Now, researchers at The Ohio State University have determined a new way that HPV might spark cancer development – by disrupting the human DNA sequence with repeating loops when the virus is inserted into host-cell DNA as it replicates.
illustration of cancer-causing genes being amplified.


Tuesday, April 15, 2014 - 09:00

Delivering chemotherapy drugs in nanoparticle form could help reduce side effects by targeting the drugs directly to the tumors. In recent years, scientists have developed nanoparticles that deliver one or two chemotherapy drugs, but it has been difficult to design particles that can carry any more than that in a precise ratio.